Website Search
Find information on spaces, staff, and services.
Find information on spaces, staff, and services.
| LEADER | 11780nam 2200481 i 4500 | |
| 001 | 991016002821402133 | |
| 005 | 20230630000947.0 | |
| 006 | m o d | | |
| 007 | cr cnu|||||||| | |
| 008 | 211009s2021 njua ob 001 0 eng d | |
| 020 | $a1-119-59956-3 | |
| 020 | $a1-119-59958-X | |
| 020 | $a1-119-59955-5 | |
| 035 | $a(CKB)4100000011798709 | |
| 035 | $a(MiAaPQ)EBC6516142 | |
| 035 | $a(Au-PeEL)EBL6516142 | |
| 035 | $a(OCoLC)1243545829 | |
| 035 | $a(EXLCZ)994100000011798709 | |
| 040 | $aMiAaPQ$beng$erda$epn$cMiAaPQ$dMiAaPQ | |
| 050 | _4 | $aRM171$b.M338 2021 |
| 082 | 0_ | $a615.39$223 |
| 130 | 0_ | $aTransfusion medicine (McCullough) |
| 245 | 00 | $aTransfusion medicine /$cedited by Jeffrey McCullough. |
| 250 | $a5th ed. | |
| 264 | _1 | $aHoboken, New Jersey :$bJohn Wiley & Sons, Incorporated,$c[2021] |
| 264 | _4 | $c©2021 |
| 300 | $a1 online resource (595 pages) :$billustrations | |
| 336 | $atext$btxt$2rdacontent | |
| 337 | $acomputer$bc$2rdamedia | |
| 338 | $aonline resource$bcr$2rdacarrier | |
| 588 | $aDescription based on print version record. | |
| 504 | $aIncludes bibliographical references and index. | |
| 505 | 0_ | $aCover -- Title Page -- Copyright Page -- Contents -- Contributors -- Preface -- Chapter 1 History -- 1.1 Ancient times -- 1.2 The period 1500-1700 -- 1.3 The 1800s -- 1.4 First transfusions in the United States -- 1.5 The discovery of blood groups -- 1.6 Anticoagulation -- 1.7 Modern blood banking and blood banks -- 1.8 Cadaver blood -- 1.9 The Rh blood group system and prevention of Rh immunization -- 1.10 Coombs and antiglobulin serum -- 1.11 Plasma and the blood program during World War II -- 1.12 Plastic bags and blood components -- 1.13 Cryoprecipitate and factor VIII -- 1.14 Red cell preservation -- 1.15 Leukocyte antigens and antibodies -- 1.16 Platelet collection, storage, and transfusion -- 1.17 Apheresis -- 1.18 Granulocyte transfusions -- 1.19 Summary -- References -- Chapter 2 The Blood Supply -- 2.1 Worldwide blood supply -- US blood supply -- 2.2 Amount of blood collected -- Platelet production -- Plasma production for transfusion -- 2.3 Management of the blood supply -- 2.4 Other activities of community blood centers -- 2.5 The plasma collection system -- Plasma definitions -- Federally licensed plasma collection and manufacturing organizations -- Plasma collection activity -- 2.6 Nongovernmental blood bank organizations -- AABB, formerly the American Association of Blood Bank -- America's Blood Centers -- Plasma Protein Therapeutics Association -- 2.7 World Health Organization -- 2.8 Federation of Red Cross and Red Crescent Societies -- 2.9 International Society for Blood Transfusion -- 2.10 Regulation of the blood supply system -- US Federal Regulation -- Other required licensure -- Voluntary accreditation of blood banks -- College of American Pathologists Accreditation Program -- References -- Chapter 3 Recruitment of Blood Donors -- 3.1 Demographic characteristics of blood donors -- Gender -- Age -- Race/Ethnicity. |
| 505 | 8_ | $aEducation and socioeconomic characteristics -- Employment -- Other social characteristics -- 3.2 Motivation of whole blood donors -- Psychosocial theories applicable to blood donation -- Integrated model -- Theory of planned behavior -- Giving and not giving -- 3.3 The donation experience and factors that influence continued donation -- Social influences on blood donation and social media -- Family history of donation or blood use -- The donation situation -- Organizational influences -- Role of incentives -- 3.4 Whole blood donor recruitment strategies -- 3.5 Apheresis donor recruitment -- 3.6 Bone marrow donors -- References -- Chapter 4 Blood Donor Medical Assessment, Collection, and Complications -- 4.1 Blood collection -- 4.2 Medical assessment of whole blood donors -- Registration -- Obtaining medical history -- Patients with hemochromatosis as blood donors -- Physical examination of the blood donor -- Special blood donations -- 4.3 Collection of whole blood -- Labeling -- Blood bags -- Anticoagulant preservative solutions -- Selection of the vein and preparation of the venipuncture site -- Venipuncture -- Blood collection -- 4.4 Postdonation care and adverse reactions to blood donation -- Postdonation care -- Adverse reactions -- Severe reactions to blood donation -- Seizures -- Nerve injuries -- Hematoma, arterial puncture, and thrombosis -- 4.5 Therapeutic bleeding -- 4.6 Medical assessment of apheresis donors -- General assessment -- Plateletpheresis donors -- Red cell loss -- Blood volume shifts -- Potential complications of serial donations -- Platelet depletion -- Leukapheresis donors -- Plasmapheresis donors -- Allogeneic donors for hematopoietic cell transplantation -- Physical examination of apheresis donors -- 4.7 Adverse reactions in apheresis donors -- General -- Vasovagal reactions -- Anticoagulation -- Citrate toxicity. |
| 505 | 8_ | $aCirculatory effects -- Air embolus -- Hematoma -- Mechanical hemolysis -- Platelet depletion or damage -- Lymphocyte depletion -- Complications unique to granulocyte donation -- Complications unique to plasmapheresis -- Complications unique to mononuclear cell apheresis for collection of peripheral blood stem cells -- References -- Chapter 5 Preparation, Storage, and Characteristics of Whole Blood, Blood Components, and Plasma Derivatives -- 5.1 Whole blood preparation and storage -- 5.2 Preparation of blood components from whole blood -- Anticoagulant-preservative solutions -- Blood processing for the preparation of components -- Red blood cells -- Frozen or deglycerolized red blood cells -- Leukocyte-reduced red blood cells -- Fresh frozen plasma -- Liquid plasma (never frozen) -- 5.3 Cryoprecipitate -- Description of component -- Thawing -- 5.4 Platelet concentrates-whole blood -- Description of component -- 5.5 Granulocytes -- 5.6 Irradiation of blood components -- 5.7 Hematopoietic stem and progenitor cells -- 5.8 Plasma derivatives -- General -- Coagulation factor concentrates -- Fibrinogen -- Immune serum globulins -- 5.9 Pathogen-inactivated blood components -- Solvent-detergent plasma (Octaplas) -- Fresh frozen plasma -- Platelets -- Red cells -- 5.10 Universal red cells -- Enzymatic cleavage of ABO and Rh antigen -- Masking ABO antigens -- 5.11 Blood substitutes -- Potential clinical uses and impact of hemoglobin substitutes -- References -- Chapter 6 Production of Components by Apheresis -- 6.1 Apheresis instruments -- Fresenius Kabi Amicus Separator -- Fresenius Kabi Alyx -- Terumo Trima Accel -- Haemonetics Instruments -- 6.2 Plateletpheresis -- Single-donor platelet concentrates -- Function and storage of platelets obtained by apheresis -- 6.3 Erythrocytapheresis -- 6.4 Leukapheresis for the collection of granulocytes. |
| 505 | 8_ | $aHydroxyethyl starch in leukapheresis -- Stimulation of donors with corticosteroid or G-CSF prior to leukapheresis -- Filtration leukapheresis -- Function of granulocytes obtained by leukapheresis -- Storage of granulocytes for transfusion -- Donor-recipient matching for granulocyte transfusion -- 6.5 Leukapheresis for the collection of mononuclear cells -- 6.6 Leukapheresis for the collection of peripheral blood stem cells -- Collection procedures -- Effects of peripheral blood stem cell collection on normal donors -- Characteristics of the peripheral blood stem cell concentrates -- Quality control of peripheral blood stem cell concentrates -- Storage of peripheral blood stem cells -- 6.7 Donor selection and complications of cytapheresis in normal donors -- 6.8 Plasmapheresis and source plasma -- References -- Chapter 7 Laboratory Testing of Donated Blood -- 7.1 Background -- 7.2 Safety of the blood supply -- 7.3 Blood component testing -- ABO typing -- Rh typing -- Red blood cell antibody detection -- ABO antibody titers -- Direct antiglobulin testing -- 7.4 Testing for transmissible diseases -- General concepts of infectious disease testing -- Testing in resource‐limited settings -- Managing the results of infectious disease testing -- HIV testing -- Hepatitis B testing -- Hepatitis C testing -- Human T-cell lymphotropic virus testing -- West Nile virus testing -- Zika virus testing -- Testing for babesiosis -- Syphilis testing -- Chagas' disease testing -- Cytomegalovirus testing -- Bacterial testing of platelets -- 7.5 Other laboratory testing -- HLA antibody testing -- Extended blood group antigen typing -- Role of platelet antigen typing -- Role of platelet serology -- Parvovirus and hepatitis A virus testing -- Hemoglobin S testing -- Screening donors for IgA deficiency -- 7.6 Summary -- References -- Chapter 8 Blood Groups. |
| 505 | 8_ | $a8.1 Red blood cell antigens and groups -- 8.2 ABO system -- Genes and composition -- A and B subgroups -- Bombay type -- Antigen distribution and subgroups -- Antibodies of the ABH system -- 8.3 The Rh system -- Discovery -- Nomenclature and genetics -- Structure and composition of the D antigen -- Weak D, D variant, Du, and partial D -- Rh null type -- Rh antibodies -- 8.4 Other red cell blood groups -- Kell system -- Duffy system -- Kidd system -- Lutheran system -- MNSs system -- P system -- Lewis system -- LW system -- Diego (Di) -- Cartwright (Yt) -- XG system -- Dombrock (Do) -- Scianna (Sc) -- Colton (Co) -- Rogers (Rg) and Chido (Ch) -- Gerbich (Ge) -- Cromer (Cr) -- Knops (Kn) -- Indian (In) -- OK system -- RAPH system -- JMH system -- GIL -- Ii blood group antigens -- Human leukocyte antigen -- 8.5 Antibodies to red cell antigens -- 8.6 Function of molecules containing red cell antigens -- Red cell structure -- Red cell function -- Receptors and adhesion molecules -- Transport protein -- Complement regulatory molecules -- Enzymatic activity -- Microbial receptor -- 8.7 Platelets -- 8.8 Granulocytes -- References -- Chapter 9 Laboratory Detection of Blood Groups and Provision of Red Cells -- 9.1 Immunologic mechanisms of red cell destruction -- 9.2 Methods of detecting red cell antibody-antigen reactions -- Factors that affect agglutination -- Direct agglutination -- Techniques to enhance red cell antibody detection -- Techniques for detecting red cell antigen-antibody reactions -- 9.3 The antiglobulin test -- Anti-human globulin serum -- The indirect antiglobulin (indirect Coombs) test -- The direct antiglobulin (Coombs) test -- 9.4 Red cell compatibility testing -- Positive identification of recipient and blood sample -- Review of transfusion service records for results of previous testing of samples from the recipient. |
| 505 | 8_ | $aMedication and Biologicals. |
| 650 | _0 | $aBlood banks$xorganization & administration. |
| 650 | _0 | $aBlood$xTransfusion. |
| 650 | _0 | $aBlood donors. |
| 776 | $z1-119-59953-9 | |
| 700 | 1_ | $aMcCullough, Jeffrey,$d1938-$eeditor. |
| 906 | $aBOOK | |